Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH
Top

The D2d study

print
PRINT
insite
SEARCH

Update 06-08-2019 | No evidence for Vitamin D in type 2 diabetes prevention

Presenters: Myrlene A. Staten, MD; Erin S. Leblanc, MD, MPH; Anastassios G. Pittas, MD, MS.

Friday 7 June: 11:30–12:30

The D2d (Vitamin D and type 2 diabetes) study has investigated whether daily supplementation with vitamin D3 can reduce the risk for progression to type 2 diabetes in people with prediabetes based on at least two criteria.

Participants were enrolled regardless of vitamin D status and randomly assigned to take vitamin D3 at a dose of 4000 IU – higher than the recommended 600–800 IU/day supplemental dose – or matching placebo. The aim was to continue treatment for an average of 3 years.

More on this trial

print
PRINT